Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Syngene International

Sector: Healthcare | Industry: Drugs & Pharma
R 302.20 -7.75  | -2.50% 15.08% 31.55 12,216.00
NSE Price: Dec 10, 15:32 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Dec 10, 15:32 302.20 -7.75 -2.50% 309.00 309.95 157,457 301.50 - 311.55
BSE Dec 10, 15:33 302.00 -8.10 -2.61% 313.75 310.10 2,745 301.90 - 313.75
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue1,886.501,825.601,423.10-- --
Other Income84.4076.20136.10-- --
Total Income1,970.901,901.801,559.20-- --
Total Expenditure1,330.801,289.901,032.60-- --
Operating Profit640.10611.90526.60-- --
Interest31.7032.3022.70-- --
PBDT608.40579.60503.90-- --
Depreciation187.00164.20131.40-- --
PBT & Exceptional Items421.40415.40372.50-- --
Exceptional Items71.30---- --
Profit before Tax492.70415.40372.50-- --
Provision for Tax105.5083.8067.10-- --
Profit after Tax387.20331.60305.40-- --
Minority Interest0.00---- --
Share of Associate0.00---- --
Consolidated Profit387.20331.60305.40-- --
 
LiabilitiesR Cr
Share Capital400.00200.00200.00-- --
Total Reserves1,690.201,740.401,492.20-- --
Shareholder's Funds2,090.201,968.401,720.40-- --
Minority Interest----- --
Long Term Borrowings353.20361.70585.50-- --
Other Non Current Liabilities361.30244.8099.50-- --
Current Liabilities1,150.901,128.60783.60-- --
Total Debt*-813.30787.40-- --
Total Liabilities3,955.603,703.503,189.00-- --
 
AssetsR Cr
Net Block1,614.701,336.801,030.40-- --
Non Current Investments325.0040.00--- --
Other Non-Current Assets650.30562.60438.40-- --
Current Investments541.00716.00157.70-- --
Cash and Bank235.90436.90967.40-- --
Other Current Assets588.70611.20595.10-- --
Net Current Assets214.70635.50936.60-- --
Miscellaneous Exp. Not Written Off----- --
Total Assets3,955.603,703.503,189.00-- --
 
Cash FlowR Cr
From Operations-630.40446.20-- --
From Investing Activities--646.50-349.30-- --
From Finance Activities--72.40-78.70-- --
Net Inflow/Outflow--88.5018.20-- --
 
Key Ratios
Adjusted EPS (Rs)9.688.297.64-- --
Adjusted Book Value (Rs)52.2648.5142.31-- --
Dividend per Share (Rs)-0.501.00-- --
Cash Flow per Share (Rs)-31.5222.31-- --
Debt to Equity0.170.420.47-- --
Current Ratio1.191.562.20-- --
ROCE (%)-16.9315.76-- --
RONW (%)21.0918.2618.05-- --
Operating Margin (%)33.9333.5237.00-- --
Net Margin (%)19.6517.4419.59-- --
Revenue Growth (%)16.3528.280.00-- --
Net Profit Growth (%)24.508.580.00-- --
EPS Growth (%)24.508.580.00-- --
Book Value Growth (%)-14.670.00-- --
 
Market Cues
Close Price (Rs)309.95297.65298.60-- --
High Price (Rs)369.00350.00336.00-- --
Low Price (Rs)250.05250.05215.05-- --
Market Cap (Rs Cr)12,216.0011,759.0011,776.00-- --
Price / Earnings31.5535.4638.56-- --
Price / Book Value5.846.066.96-- --
Dividend Yield (%)0.080.090.17-- --
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
6.13
Piotroski F-Score
7
Modified C-Score
0
1-Year Price to Earnings
32.04
1-Year Price to Book
5.93
Earnings Yield
EBIT / Enterprise value
4.35%
PEG
Price / Earnings to growth ratio
0.26
Related Stocks
  Current Price   Chng %
Abbott India R12,508.05 -2.00%
Alkem Laboratories R2,085.85 -0.07%
Aurobindo Pharma R432.55 -3.51%
Biocon R289.65 +0.16%
Cadila Healthcare R260.95 +0.58%
Glaxosmithkline Pharma R1,609.70 -0.30%
Lupin R752.80 -0.42%
Pfizer R4,227.90 -1.35%
Piramal Enterprises R1,611.60 -2.20%
Torrent Pharmaceuticals R1,824.95 -2.24%
As on Dec 10, 15:32